Although very similar in sequence, the four subclasses of human immunoglobulin G (IgG) differ markedly in their ability to activate complement. Glu318-Lys320-Lys322 has been identified as a key binding motif for the first component of complement, C1q, and is present in all isotypes of Ig capable of activating complement. This motif, however, is present in all subclasses of human IgG, including those that show little (IgG2) or even no (IgG4) complement activity. Using point mutants of chimeric antibodies, we have identified specific residues responsible for the differing ability of the IgG subclasses to fix complement. In particular, we show that Ser at position 331 in gamma 4 is critical for determining the inability of that isotype to bind...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Although very similar in sequence, the four subclasses of human immunoglobulin G (IgG) differ marked...
Humanized antibodies are likely to have a major role in therapy and it is important to define their ...
Using domain switch chimeric antibodies, we confirm the important role of CH2 in complement activati...
Using domain switch chimeric antibodies, we confirm the important role of CH2 in complement activati...
Using domain switch chimeric antibodies, we confirm the important role of CH2 in complement activati...
The first step in the activation of the classical complement pathway by immune complexes involves th...
grantor: University of TorontoThe IgM and IgG classes of immunoglobulins share an importan...
grantor: University of TorontoThe IgM and IgG classes of immunoglobulins share an importan...
Binding of the complement component C1q to the CH2 domain of antigen-bound immunoglobulin gamma (IgG...
Of the four human immunoglobulin G (IgG) subclasses, IgG4 is considered the least inflammatory, in p...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Although very similar in sequence, the four subclasses of human immunoglobulin G (IgG) differ marked...
Humanized antibodies are likely to have a major role in therapy and it is important to define their ...
Using domain switch chimeric antibodies, we confirm the important role of CH2 in complement activati...
Using domain switch chimeric antibodies, we confirm the important role of CH2 in complement activati...
Using domain switch chimeric antibodies, we confirm the important role of CH2 in complement activati...
The first step in the activation of the classical complement pathway by immune complexes involves th...
grantor: University of TorontoThe IgM and IgG classes of immunoglobulins share an importan...
grantor: University of TorontoThe IgM and IgG classes of immunoglobulins share an importan...
Binding of the complement component C1q to the CH2 domain of antigen-bound immunoglobulin gamma (IgG...
Of the four human immunoglobulin G (IgG) subclasses, IgG4 is considered the least inflammatory, in p...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...
Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feat...